ANGELA STURDIVANT: Open Payments
NPI 1942955570 · ELKINS, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,042 in 54 payments from 9 companies in 2025. Trend: 2023 $682 · 2024 $915 · 2025 $1,042
Food & beverage: $1,028Education: $14
| Company | Payments | Amount |
|---|---|---|
| Genentech USA, Inc. | 12 | $262 |
| Novartis Pharmaceuticals Corporation | 9 | $228 |
| GlaxoSmithKline, LLC. | 16 | $211 |
| ARS Pharmaceuticals Operations, Inc. | 5 | $111 |
| Optinose US, Inc. | 3 | $74 |
| Amgen Inc. | 4 | $67 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $38 |
| AstraZeneca Pharmaceuticals LP | 2 | $30 |
| JAZZ PHARMACEUTICALS INC. | 1 | $21 |
Products named: XOLAIR, NUCALA, NEFFY, Xhance, TEZSPIRE, TRELEGY ELLIPTA, EOHILIA, FASENRA.
Industry payments across WV — which companies pay providers there.
